Complete Care Medical, Inc. Announces Agreement Between Carepharm LTC and RF Drugstore, Inc.

Agreement Expected to Fuel Rapid Growth in Carepharm's Mail Order Pharmacy Business


HOUSTON, Aug. 1, 2005 (PRIMEZONE) -- Complete Care Medical, Inc. (Pink Sheets:CCMI) is pleased to announce that its wholly owned subsidiary, Carepharm LTC Pharmacy, has entered into a referral agreement with RF Drugstore, Inc., in which Carepharm will become the generic drug provider for all RF Drugstore patients. RF Drugstore, Inc., headquartered in Toronto, Canada, is one of the largest Canadian mail-order pharmacies and is the pharmacy of choice for nearly 100,000 patients from throughout the United States.

"The affiliation between Carepharm and RF Drugstore will quickly add patients to our pharmacy census and increase our revenues," said J.P. Monteverde, CEO of Complete Care Medical, Inc. "Millions of U. S. citizens have learned that it is possible to save as much as 70 percent on brand-name prescription drugs by buying from Canadian pharmacies. However, generic drugs are generally less expensive in the United States. In order for RF Drugstore to provide its patients with the lowest prices on all drugs, generic drug prescriptions previously filled by RF Drugstore will now be filled by Carepharm. This agreement represents another step forward in our expansion as a leading mail order pharmaceutical and disease management provider."

Through its subsidiaries, Complete Care Medical, Inc. provides patients in all 50 states with lower-cost alternatives for disease management, medical supplies, and prescription pharmaceuticals. In addition, Complete Care Medical's discount services and medication program offers healthcare payers, healthcare providers, healthcare professionals, and patients with easy access to utilization and compliance data in order to improve patient outcomes and improve quality of life.

For more information: www.ccmedicalinc.com

Forward-looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties or other factors which may cause actual results, performance, or achievements of the Company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as: the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels.

All information in this release is as of the date of this release. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.


            

Contact Data